Patents Assigned to University of Colorado
  • Publication number: 20240260943
    Abstract: Diagnostic imaging of deep targets in the body requires sufficient signal amplitude to overcome effects such as attenuation with depth and thermal noise produced in signal reception. Coded excitation provides several strategies to increase the total transmitted energy without exceeding peak amplitude safety limits. Temporal coding has proven particularly effective, but these frequency or amplitude modulation techniques require additional transmit capabilities and often require complex processing to reduce decoding artifacts. An alternative code is presented based on time delays that relies on repeated transmit pulses that can be decoded using spatiotemporal synthetic aperture processing. A 16-pulse code is demonstrated that achieves an 11.1 dB improvement in signal-to-noise ratio (SNR) while maintaining axial resolution and sufficient range lobe performance.
    Type: Application
    Filed: August 30, 2022
    Publication date: August 8, 2024
    Applicant: The Regents of the University of Colorado, a body
    Inventor: Nick Bottenus
  • Patent number: 12054607
    Abstract: The present invention relates in part to compositions displaying stress relaxation at the polymer-filler interface. The adaptive interface (AI) formed by coupling moieties capable of dynamic covalent chemistry (DCC) within the polymer-filler interface promotes stress relaxation and yields tough, and healable composites.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: August 6, 2024
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Christopher N. Bowman, Nancy Sowan, Lewis M. Cox
  • Patent number: 12054834
    Abstract: The present disclosure provides methods for the chemical degradation of polymers, in particular to methods for the degradation of polyesters by electrochemical processes.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: August 6, 2024
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Oana Luca, Tessa Myren, Chloe Huntzinger, Taylor A Stinson
  • Patent number: 12050389
    Abstract: Dynamic windows with adjustable tint give users greater control over flow of light and heat. Reversible metal electrodeposition dynamic windows include (i) a transparent or translucent conductive electrode; (ii) an electrolyte solution in contact with the electrode, the electrolyte solution comprising metal cations that are reversibly electrodeposited onto the transparent electrode upon application of a cathodic potential; and (iii) a counter electrode. The electrolyte solution advantageously includes a small amount of an additive (e.g., an inhibitor, an accelerator, a leveler, or an organic or inorganic molecule that similarly serves to enhance the surface morphology of the metal cations during reversible metal electrodeposition onto the transparent electrode). Such enhancement of surface morphology during the reversible electrodeposition of the metal tinting layer over the electrode enhances one or more of color neutrality, transmittance characteristics of visible wavelengths (e.g.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: July 30, 2024
    Assignees: The Regents of the University of Colorado, A Body Corporate, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Michael T. Strand, Christopher Barile, Tyler S. Hernandez, Andrew L Yeang, Michael D. McGehee
  • Patent number: 12042394
    Abstract: A spinal implant device comprising a frame and a plurality of mechanical stiffness members extending from the frame, with the plurality of mechanical stiffness members being individually customized to provide a specific axial stiffness. The plurality of mechanical stiffness members may be coupled to the frame, and the plurality of mechanical stiffness members may be a plurality of wave-spring modules. A method of treating spinal disease includes determining actual spatial mechanical properties across a vertebral contact surface of a vertebra of a patient. The method may also include manufacturing a spinal implant device that has conforming spatial mechanical properties that are specific to the patient and that are based on the actual spatial mechanical properties of the vertebral contact surface. The method may include surgically implanting the spinal implant device against the vertebral contact surface such that the actual spatial mechanical properties and the conforming spatial mechanical properties align.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: July 23, 2024
    Assignee: The Regents of The University of Colorado, A Body Corporate
    Inventors: Andriy G. Noshchenko, Evalina Burger-(Van Der Walt), Vikas V. Patel, Christopher J. Kleck, Ji Ma
  • Patent number: 12043601
    Abstract: The present invention relates to the discovery of novel N-(substituted)-1H-1,2,4-triazole-3-carboxamide compounds capable of inhibiting DksA activity in a bacteria cell. In certain embodiments, the compounds are capable of killing or weakening bacteria. In another aspect, the invention relates to methods of treating bacterial infection in a subject in need thereof, the method comprising administering to the subject a compound of the invention.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: July 23, 2024
    Assignees: The Regents of the University of Colorado, National Jewish Health
    Inventors: Michael Fitzpatrick Wempe, Andres Vazquez-Torres, Shaodong Dai
  • Patent number: 12042529
    Abstract: The present invention provides a method of PEGylating a human truncated cystathionine ?-synthase protein containing a mutation of a cysteine to a serine at amino acid position 15 (htCBS C15S). The htCBS C15S was PEGylated with one of 5 kDa, 10 kDa, or 20 kDa NHS ester PEG molecules. In-process monitoring of the PEGylation process was used in the method to reduce levels of unPEGylated htCBS C15S and htCBS C15S with insufficient PEGylation. Administration of the PEGylated htCBS C15S had efficacy throughout the course of treatment for homocystinuria.
    Type: Grant
    Filed: April 5, 2022
    Date of Patent: July 23, 2024
    Assignees: The Regents Of The University Of Colorado, A Body Corporate, Travere Therapeutics Switzerland GmbH
    Inventors: Tomas Majtan, Jan P. Kraus, Erez M. Bublil, Frank Glavin, Marcia Sellos-Moura
  • Patent number: 12030958
    Abstract: Embodiments herein report compositions of alpha-1 antitrypsin fusion polypeptides or peptide derivatives thereof. In certain embodiments, compositions and methods relate to generating a construct of use in pharmaceutically acceptable compositions to treat a subject in need of alpha-1 antitrypsin therapy or treatment. In other embodiments, compositions and methods disclosed herein concern linking alpha-1 antitrypsin or derivative thereof to an immune fragment.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: July 9, 2024
    Assignees: The Regents of the University of Colorado, Konkuk University Industry Cooperation Foundation
    Inventors: Charles A. Dinarello, Soohyun Kim
  • Patent number: 12029687
    Abstract: The present invention relates to an ophthalmic knife and methods of its use for treatment of various conditions including eye diseases, such as glaucoma, using minimally invasive surgical techniques. The invention relates to a multi-blade device for cutting the tissues within the eye, for example, a trabecular meshwork (TM).
    Type: Grant
    Filed: May 10, 2022
    Date of Patent: July 9, 2024
    Assignees: The Regents of the University of Colorado, a body corporate, New World Medical, Inc.
    Inventors: Malik Y. Kahook, Khalid Mansour, Suhail Abdullah, Eric Porteous, Vijay R. Balan
  • Patent number: 12029732
    Abstract: Disclosed herein are compositions, methods, and systems useful in the prevention, management, or treatment of various conditions associated the lymphatic vasculature, including, but not limited to lymphedema. The disclosed methods and compositions are useful in reducing the activity of p53 in a subject at risk for or suffering from a disease or condition associated with lymphatic vasculature, including adults, children, infants, and embryos. Reduction in p53 activity may be achieve through reduction in one or more of p53 gene expression, p53 transcriptional activity, p53 DNA-binding affinity, etc. In many embodiments, the disease or condition is lymphedema, for example lymphedema associated with Milroy's disease, Klippel-Trenaunay and Cloves Syndromes. In many embodiments, treatment may involve administering a compound or pharmaceutically acceptable salt thereof to a subject in need thereof, exemplary compounds include, anti-p53 compounds, PFT, and PFT-?.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: July 9, 2024
    Assignee: The Regents of the University of Colorado, A Body Corporate
    Inventors: Tamara Terzian, Neil Box
  • Publication number: 20240219572
    Abstract: Through discrimination of the scattered signal polarization state, a lidar system measures a distance through semi-transparent media by the reception of single or multiple scattered signals from a scattering medium. Combined and overlapped single or multiple scattered light signals from the medium can be separated by exploiting varying polarization characteristics. This removes the traditional laser and detector pulse width limitations that determine the system's operational bandwidth, translating relative depth measurements into the conditions of two surface timing measurements and achieving sub-pulse width resolution.
    Type: Application
    Filed: March 18, 2024
    Publication date: July 4, 2024
    Applicants: The Regents of the University of Colorado, a body corporate, LiteWave Technologies, Inc.
    Inventors: Jeffrey P. THAYER, Geoffrey CROWLEY, Andrew W. GISLER, Steven MITCHELL, Matthew HAYMAN
  • Patent number: 12019127
    Abstract: A magnetographic camera may be based on an optically pumped magnetometer (OPM). The magnetographic camera may measure a spatial distribution of magnetic field produced by a sample that may be stationary in time or may dynamically vary with time. The magnetographic camera may include a magnetic field detector housing containing a vapor cell. The magnetographic camera may include a laser light source to illuminate the vapor cell causing a magnetic field image of a sample to be generated. The magnetographic camera may include an optical detector to encode and store the magnetic field image of the sample that is spatially encoded as a distribution of light.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: June 25, 2024
    Assignees: The Regents of the University of Colorado, body corporate, Moment Technologies, LLC
    Inventors: Svenja Knappe, Yoshio Okada, Sean Krzyzewski
  • Patent number: 12018081
    Abstract: A prodrug enzyme covalently photoconjugated to a live cell receptor survives endosomal proteolysis and retains its catalytic activity on the living cell membrane over multiple days. Antibody-directed enzyme prodrug therapy is a promising approach for selective treatment of solid tumors, but methods are needed to preserve enzyme activity on living cell membranes over multiple prodrug dosings. A fusion protein was designed with both an anti-epidermal growth factor receptor (EGFR) affibody and the prodrug enzyme cytosine deaminase, which can convert prodrug 5-fluorocytosine to the anticancer drug 5-fluorouracil. A benzophenone group was added at a site-specific mutation within the affibody portion, and the fusion protein was selectively and irreversibly photoconjugated to EGFR receptors expressed on membranes of live MDA-MB-468 breast cancer cells.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: June 25, 2024
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Andrew P. Goodwin, Jennifer N. Cha, Shambojit Roy, Michael D. Brasino
  • Patent number: 12012478
    Abstract: Polymers suitable for forming carbon nanotube-functionalized reverse thermal gel compositions, compositions including the polymers, and methods of forming and using the polymers and compositions are disclosed. The compositions have reverse thermal gelling properties and transform from a liquid/solution to a gel—e.g., near or below body temperature. The polymers and compositions can be injected into or proximate an area in need of treatment.
    Type: Grant
    Filed: March 21, 2023
    Date of Patent: June 18, 2024
    Assignee: The Regents of the University of Colorado
    Inventors: Daewon Park, Brisa Pena Castellanos, Susanna Bosi, Luisa Mestroni, Maurizio Prato
  • Patent number: 12011390
    Abstract: A lacrimal drug delivery device includes a reservoir configured to hold a drug. The reservoir is moveable between a relaxed state and an expanded state. A connector is fluidly coupled to the reservoir and a lumen is formed in the connector wherein the drug is configured to flow from the reservoir to an delivery site through the lumen. A hydrogel is within the lumen and configured to absorb the drug from the reservoir and deliver the drug from the lumen at the delivery site. The hydrogel includes a first section which absorbs the drug at a first rate of absorption. A delivery guide is detachably coupled to the reservoir to deliver the reservoir into a lacrimal sac of a patient.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: June 18, 2024
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Andrew Schieber, Linda Thai, Malik Kahook
  • Publication number: 20240190768
    Abstract: Cement mixtures comprising a hydration retarder comprising algae, cement additives comprising algae and/or derivatives thereof, and methods of forming and using the mixtures and additives are disclosed. The algae can be treated to form desired functional groups to tune retardation properties of the hydration retarder.
    Type: Application
    Filed: March 31, 2022
    Publication date: June 13, 2024
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Wilfred V. Srubar, III, Xu Chen
  • Patent number: 12007383
    Abstract: A method for estimating portal blood flow and hepatic function in a subject is provided. In one example, the STAT test is an in vitro simplified, convenient test intended for screening purposes that can reasonably estimate the portal blood flow from a single blood sample taken 60 minutes after orally administered deuterated-cholate. The test can be administered to a patient having, or suspected of having, Chronic Hepatitis C, Primary Sclerosing Cholangitis (PSC), Non-Alcoholic Fatty Liver Disease (NAFLD), or any chronic liver disease.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: June 11, 2024
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Gregory Thomas Everson, Steve Mark Helmke
  • Patent number: 12005066
    Abstract: Methods and compositions for treating cyanide, sulfide, or methane-thiol exposure in a subject. The compositions may include one or more cobinamide compounds, such as an amino-tetrazole-cobinamide and/or a di-(amino-tetrazole)-cobinamide.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: June 11, 2024
    Assignees: The Regents of the University of California, The Regents of the University of Colorado
    Inventors: Gerard Boss, Adriano Chan, Matthew Brenner, Sari Brenner Mahon, Vikhyat Bebarta
  • Patent number: 12007472
    Abstract: A digital direct line-of-sight (DLOS) intermediate frequency (IF) signal of a DLOS component of an RF carrier signal transmitted by a transmitter located above the surface of the earth and a digital reflected IF signal of a reflected component of the carrier signal that is reflected from a specular point (SP) on the surface of the earth are received. Modeled reference signal parameters are generated using the digital DLOS IF signal and known locations of one or more receiving antennas, the transmitter, and the SP. A reference signal is generated based on the modeled reference signal parameters and feedback of a previously estimated ??. The reference signal is correlated with the digital reflected IF signal to produce in-phase (I) and quadrature-phase (Q) correlation results. An estimated C/N0 and an estimated ?? for the digital reflected IF signal are calculated from the correlation results.
    Type: Grant
    Filed: June 21, 2023
    Date of Patent: June 11, 2024
    Assignee: The Regents of the University of Colorado
    Inventors: Yang Wang, Yu T. Morton
  • Publication number: 20240183692
    Abstract: A system for sensing phase changes in a medium includes a bidirectional interferometer having a reference arm and a sensing arm, two inputs at each of the two ends of the interferometer, and a circulator disposed between each input and the interferometer. Sources provide squeezed state pulses at an input at each end of the interferometer. Spaced-apart partial reflectors are disposed along the arms. There are detectors associated with each input. The circulators pass the squeezed state pulses into the interferometer and route reflections of the pulses to the detectors. Classical pulses may provided at the other input at each end of the interferometer.
    Type: Application
    Filed: October 20, 2023
    Publication date: June 6, 2024
    Applicant: The Regents of the University of Colorado, a body corporate
    Inventors: Juliet Gopinath, Lior Cohen, Gregory Krueper, Joshua Combes